Cargando…
Detection of a novel panel of somatic mutations in plasma cell-free DNA and its diagnostic value in hepatocellular carcinoma
Background/aims: Circulating cell-free DNA (cfDNA) contains tumor-specific alterations and could potentially serve as “liquid biopsy”. The study was to identify a novel panel of hepatocellular carcinoma (HCC)-specific mutations in plasma cfDNA and to assess its value in the diagnosis of HCC. Materia...
Autores principales: | Xiong, Yu, Xie, Cheng-Rong, Zhang, Sheng, Chen, Jin, Yin, Zhen-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605764/ https://www.ncbi.nlm.nih.gov/pubmed/31303788 http://dx.doi.org/10.2147/CMAR.S197455 |
Ejemplares similares
-
Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence
por: Ueda, Masami, et al.
Publicado: (2016) -
Somatic Mutations in Circulating Cell-Free DNA and Risk for Hepatocellular Carcinoma in Hispanics
por: Jiao, Jingjing, et al.
Publicado: (2021) -
Assessing the Diagnostic Value of Plasma-Free DNA in Prostate Cancer Screening
por: Seyedolmohadessin, Seyedeh Maryam, et al.
Publicado: (2018) -
Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumors
por: Mehrotra, Meenakshi, et al.
Publicado: (2017) -
Identification of Somatic Mutations in Plasma Cell-Free DNA from Patients with Metastatic Oral Squamous Cell Carcinoma
por: Lin, Li-Han, et al.
Publicado: (2023)